# Nabilone & Marijuana Addiction

> **NCT01025700** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of British Columbia** · enrollment: 35 (estimated)

## Conditions studied

- Marijuana Smoking

## Interventions

- **DRUG:** Cesemat

## Key facts

- **NCT ID:** NCT01025700
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2010-06
- **Final completion:** 2010-10
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2011-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01025700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01025700, "Nabilone & Marijuana Addiction". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01025700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*